mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration

mRNA has emerged as an important biomolecule in the global call for the development of therapies during the COVID-19 pandemic. Synthetic in vitro-transcribed (IVT) mRNA can be engineered to mimic naturally occurring mRNA and can be used as a tool to target “undruggable” diseases. Recent advancement...

Full description

Bibliographic Details
Main Authors: Palas K. Chanda, Roman Sukhovershin, John P. Cooke
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/1/187
_version_ 1827599823839166464
author Palas K. Chanda
Roman Sukhovershin
John P. Cooke
author_facet Palas K. Chanda
Roman Sukhovershin
John P. Cooke
author_sort Palas K. Chanda
collection DOAJ
description mRNA has emerged as an important biomolecule in the global call for the development of therapies during the COVID-19 pandemic. Synthetic in vitro-transcribed (IVT) mRNA can be engineered to mimic naturally occurring mRNA and can be used as a tool to target “undruggable” diseases. Recent advancement in the field of RNA therapeutics have addressed the challenges inherent to this drug molecule and this approach is now being applied to several therapeutic modalities, from cancer immunotherapy to vaccine development. In this review, we discussed the use of mRNA for stem cell generation or enhancement for the purpose of cardiovascular regeneration.
first_indexed 2024-03-09T04:23:04Z
format Article
id doaj.art-8d7b0214d9cd419784df169a42c0f00c
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T04:23:04Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-8d7b0214d9cd419784df169a42c0f00c2023-12-03T13:44:52ZengMDPI AGCells2073-44092021-01-0110118710.3390/cells10010187mRNA-Enhanced Cell Therapy and Cardiovascular RegenerationPalas K. Chanda0Roman Sukhovershin1John P. Cooke2RNA Therapeutics Program, Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX 77030, USARNA Therapeutics Program, Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX 77030, USARNA Therapeutics Program, Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, 6670 Bertner Ave., Houston, TX 77030, USAmRNA has emerged as an important biomolecule in the global call for the development of therapies during the COVID-19 pandemic. Synthetic in vitro-transcribed (IVT) mRNA can be engineered to mimic naturally occurring mRNA and can be used as a tool to target “undruggable” diseases. Recent advancement in the field of RNA therapeutics have addressed the challenges inherent to this drug molecule and this approach is now being applied to several therapeutic modalities, from cancer immunotherapy to vaccine development. In this review, we discussed the use of mRNA for stem cell generation or enhancement for the purpose of cardiovascular regeneration.https://www.mdpi.com/2073-4409/10/1/187RNA therapeuticscell therapycardiovascular regenerationinflammatory signalingnuclear reprogrammingiPSCs
spellingShingle Palas K. Chanda
Roman Sukhovershin
John P. Cooke
mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration
Cells
RNA therapeutics
cell therapy
cardiovascular regeneration
inflammatory signaling
nuclear reprogramming
iPSCs
title mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration
title_full mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration
title_fullStr mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration
title_full_unstemmed mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration
title_short mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration
title_sort mrna enhanced cell therapy and cardiovascular regeneration
topic RNA therapeutics
cell therapy
cardiovascular regeneration
inflammatory signaling
nuclear reprogramming
iPSCs
url https://www.mdpi.com/2073-4409/10/1/187
work_keys_str_mv AT palaskchanda mrnaenhancedcelltherapyandcardiovascularregeneration
AT romansukhovershin mrnaenhancedcelltherapyandcardiovascularregeneration
AT johnpcooke mrnaenhancedcelltherapyandcardiovascularregeneration